[go: up one dir, main page]
This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
2010 1
2014 2
2015 1
2017 1
2018 1
2020 2
2021 1
2022 2
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
IgG4-Related Fibrous Thyroiditis (Riedel's Thyroiditis): A Case Report.
Navarro-Sánchez V, Marín-Castañeda LA, Gallegos CA, Quiroz O, Ahumada-Ayala M. Navarro-Sánchez V, et al. Among authors: gallegos ca. Am J Case Rep. 2020 Nov 12;21:e928046. doi: 10.12659/AJCR.928046. Am J Case Rep. 2020. PMID: 33177482 Free PMC article.
Evaluating the immunologically "cold" tumor microenvironment after treatment with immune checkpoint inhibitors utilizing PET imaging of CD4 + and CD8 + T cells in breast cancer mouse models.
Lu Y, Houson HA, Gallegos CA, Mascioni A, Jia F, Aivazian A, Song PN, Lynch SE, Napier TS, Mansur A, Larimer BM, Lapi SE, Hanker AB, Sorace AG. Lu Y, et al. Among authors: gallegos ca. Breast Cancer Res. 2024 Jun 25;26(1):104. doi: 10.1186/s13058-024-01844-3. Breast Cancer Res. 2024. PMID: 38918836 Free PMC article.
[89Zr]-CD8 ImmunoPET imaging of glioblastoma multiforme response to combination oncolytic viral and checkpoint inhibitor immunotherapy reveals CD8 infiltration differential changes in preclinical models.
Gallegos CA, Lu Y, Clements JC, Song PN, Lynch SE, Mascioni A, Jia F, Hartman YE, Massicano AVF, Houson HA, Lapi SE, Warram JM, Markert JM, Sorace AG. Gallegos CA, et al. Theranostics. 2024 Jan 1;14(3):911-923. doi: 10.7150/thno.89206. eCollection 2024. Theranostics. 2024. PMID: 38250045 Free PMC article.
Safety of anacetrapib in patients with or at high risk for coronary heart disease.
Cannon CP, Shah S, Dansky HM, Davidson M, Brinton EA, Gotto AM, Stepanavage M, Liu SX, Gibbons P, Ashraf TB, Zafarino J, Mitchel Y, Barter P; Determining the Efficacy and Tolerability Investigators. Cannon CP, et al. N Engl J Med. 2010 Dec 16;363(25):2406-15. doi: 10.1056/NEJMoa1009744. Epub 2010 Nov 17. N Engl J Med. 2010. PMID: 21082868 Free article. Clinical Trial.
14 results